EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels

Jimin Hao, Man Liu, Zhigang Zhou, Chunling Zhao, Liping Dai, Songyun Ouyang

PeerJ · 2024

DOI: 10.7717/peerj.18618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Jimin Hao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Sleep Medicine, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, ErbB Receptors, Lung Neoplasms, Tomography, X-Ray Computed. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 60% of Asian populations with non-small cell lung cancer (NSCLC) harbor epidermal growth factor receptor (EGFR) gene mutations, marking it as a pivotal target for genotype-directed therapies. Currently, determining EGFR mutation status relies on DNA sequencing of histological or cytological specimens. This study presents a predictive model integrating clinical parameters, computed tomography (CT) characteristics, and serum tumor markers to forecast EGFR mutation status in NSCLC patients.

Methods

Retrospective data collection was conducted on NSCLC patients diagnosed between January 2018 and June 2019 at the First Affiliated Hospital of Zhengzhou University, with available molecular pathology results. Clinical information, CT imaging features, and serum tumor marker levels were compiled. Four distinct models were employed in constructing the diagnostic model. Model diagnostic efficacy was assessed through receiver operating characteristic (ROC) area under the curve (AUC) values and calibration curves. DeLong’s test was administered to validate model robustness.

Results

Our study encompassed 748 participants. Logistic regression modeling, trained with the aforementioned variables, demonstrated remarkable predictive capability, achieving an AUC of 0.805 (95% confidence interval (CI) [0.766–0.844]) in the primary cohort and 0.753 (95% CI [0.687–0.818]) in the validation cohort. Calibration plots suggested a favorable fit of the model to the data.

Conclusions

The developed logistic regression model emerges as a promising tool for forecasting EGFR mutation status. It holds potential to aid clinicians in more precisely identifying patients likely to benefit from EGFR molecular testing and facilitating targeted therapy decision-making, particularly in scenarios where molecular testing is impractical or inaccessible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungErbB ReceptorsLung NeoplasmsTomography, X-Ray ComputedMutationBiomarkers, TumorHumansFemaleMaleMiddle AgedRetrospective StudiesAgedLogistic ModelsAdultROC Curve

Stichwörter der Autor:innen

CT imaging featuresClinical characteristicsEpidermal growth factor receptor (EGFR)Logistic regressionNon-small cell lung cancer (NSCLC)Tumor marker levels

Substanzen

ErbB ReceptorsEGFR protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Respiratory and Sleep Medicine, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
  • Henan Institute of Medical and Pharmaceutical Sciences & Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou, Henan, China.
  • Laboratory of Molecular Biology, Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital), Zhengzhou, Henan, China.
  • Department of Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hao, J., Liu, M., Zhou, Z., Zhao, C., Dai, L., & Ouyang, S. (2024). Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels. PeerJ. https://doi.org/10.7717/peerj.18618

Vancouver

Hao J, Liu M, Zhou Z, Zhao C, Dai L, Ouyang S. Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels. PeerJ. 2024. doi:10.7717/peerj.18618

BibTeX
@article{Hao2024,
  author = {Hao, Jimin and Liu, Man and Zhou, Zhigang and Zhao, Chunling and Dai, Liping and Ouyang, Songyun},
  title = {Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.18618}
}
Kostenlos starten →